Isoptin

Verapamil hydrochloride, the active ingredient in Isoptin, is a calcium channel blocker presented as an intravenous formulation for injection use. It is employed to manage high blood pressure, chest pain from angina, and certain rapid heart rhythms in adult patients.

GNH USA supplies Isoptin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, delivering the product through regulated distribution channels that meet EU quality and compliance standards.

Isoptin (verapamil) is used in cardiovascular therapy to control blood pressure, relieve angina, and regulate abnormal heart rhythms. - Hypertension: lowers systemic blood pressure by vasodilation of arterial smooth muscle. - Angina pectoris: reduces myocardial oxygen demand and improves coronary blood flow, relieving chest pain. - Supraventricular tachyarrhythmias: slows atrioventricular nodal conduction, helping to restore normal heart rhythm.

Like all medications, Isoptin may cause adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate pain often occurring early in therapy. - Flushing: transient warmth and redness of the skin. - Dizziness or light‑headedness, especially when standing quickly. - Peripheral edema: swelling of the ankles or feet. - Constipation: reduced bowel movements. - Nausea: mild stomach upset.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure that may cause fainting. - Heart block or advanced AV conduction disturbances. - Ventricular arrhythmias: potentially life‑threatening irregular heartbeats. - Hepatic dysfunction: abnormal liver enzyme elevations. - Allergic reactions: rash, itching, or anaphylaxis. - Myocardial infarction: rare occurrence of heart attack.

Prior to initiating Isoptin therapy, clinicians should consider several safety precautions to minimize risk. - Cardiac function assessment: evaluate for existing heart block, severe left ventricular dysfunction, or recent myocardial infarction. - Concomitant beta‑blocker use: monitor for excessive bradycardia or AV block. - Liver impairment: adjust dosing and monitor hepatic function. - Renal impairment: use caution in severe renal failure and monitor electrolytes. - Pregnancy and lactation: use only if clearly needed; benefits must outweigh potential risks. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Isoptin can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Beta‑blockers: may cause excessive bradycardia or AV block. - Digoxin: verapamil can increase digoxin levels, raising toxicity risk. - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): can raise verapamil concentrations. - Diltiazem: additive effects on AV nodal conduction. - Quinidine: may increase verapamil plasma levels.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce verapamil effectiveness. - Diuretics: can enhance hypotensive effect. - Statins metabolized by CYP3A4 (e.g., simvastatin): increased risk of myopathy. - NSAIDs: may diminish antihypertensive response. - Alcohol: can potentiate hypotension.